Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 5-year average of -186.42%, near the high end of its 5-year range (-3073627.91%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
-186.42%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Immuneering Corporation
Market Cap
$139.04M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-186.42%
Market Cap
$139.47M
Operating Margin
-221.72%
TTM Avg
-110.86%
3Y Avg
-55.43%
5Y Avg
-36.95%
Market Cap
$139.84M
Operating Margin
-102.41%
TTM Avg
-243.38%
3Y Avg
-183.77%
5Y Avg
-176.77%
Market Cap
$137.80M
Operating Margin
-3.66%
TTM Avg
-13.20%
3Y Avg
-25.26%
5Y Avg
-22.69%
Market Cap
$136.67M
Operating Margin
-410.23%
TTM Avg
-412.58%
3Y Avg
-412.58%
5Y Avg
-412.58%
Market Cap
$136.57M
Operating Margin
-34.07%
TTM Avg
-27.91%
3Y Avg
-72.83%
5Y Avg
-67.42%
Market Cap
$143.10M
Operating Margin
-827.76%
TTM Avg
-1064.28%
3Y Avg
-1054.91%
5Y Avg
-3927.73%
Market Cap
$143.60M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$143.84M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immuneering Corporation (IMRX) | $139.04M | 0.00% | 0.00% | 0.00% | -186.42% |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | -221.72% | -110.86% | -55.43% | -36.95% |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | -102.41% | -243.38% | -183.77% | -176.77% |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.80M | -3.66% | -13.20% | -25.26% | -22.69% |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.67M | -410.23% | -412.58% | -412.58% | -412.58% |
| Organigram Global Inc. (OGI)vs › | $136.57M | -34.07% | -27.91% | -72.83% | -67.42% |
| Nyxoah S.A. (NYXH)vs › | $143.10M | -827.76% | -1064.28% | -1054.91% | -3927.73% |
| Protara Therapeutics, Inc. (TARA)vs › | $143.60M | 0.00% | 0.00% | 0.00% | 0.00% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $143.84M | 0.00% | 0.00% | 0.00% | 0.00% |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -3073627.91% |
| 2022-09-30 | -34362.04% |
| 2022-06-30 | -12334.43% |
| 2022-03-31 | -7036.37% |
| 2021-12-31 | -5863.02% |
| 2021-09-30 | -1772.01% |
| 2021-06-30 | -1210.67% |
| 2021-03-31 | -833.47% |
| 2020-12-31 | -877.56% |
| 2020-09-30 | -644.66% |
| 2020-06-30 | -750.08% |
| 2020-03-31 | -670.58% |
